Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation

The most important goals for the field of immuno-oncology are to improve the response rate and increase the number of tumor indications that respond to immunotherapy, without increasing adverse side effects. One approach to achieve these goals is to use tumor-directed immunotherapy, i.e., to focus t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellmark, Peter, Mangsbo, Sara M., Furebring, Christina, Norlén, Per, Tötterman, Thomas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222923/
https://www.ncbi.nlm.nih.gov/pubmed/27714433
http://dx.doi.org/10.1007/s00262-016-1909-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222923/
https://www.ncbi.nlm.nih.gov/pubmed/27714433
http://dx.doi.org/10.1007/s00262-016-1909-3

Ejemplares similares